Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) EBITDA (2020 - 2025)

Historic EBITDA for Clene (CLNN) over the last 6 years, with Q3 2025 value amounting to -$8.8 million.

  • Clene's EBITDA fell 1062.65% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.6 million, marking a year-over-year increase of 1482.59%. This contributed to the annual value of -$39.5 million for FY2024, which is 2015.84% up from last year.
  • Latest data reveals that Clene reported EBITDA of -$8.8 million as of Q3 2025, which was down 1062.65% from -$7.4 million recorded in Q2 2025.
  • In the past 5 years, Clene's EBITDA registered a high of $28.9 million during Q3 2021, and its lowest value of -$39.7 million during Q1 2021.
  • For the 5-year period, Clene's EBITDA averaged around -$7.7 million, with its median value being -$7.9 million (2024).
  • Its EBITDA has fluctuated over the past 5 years, first surged by 38035.56% in 2021, then tumbled by 98088.08% in 2023.
  • Quarter analysis of 5 years shows Clene's EBITDA stood at $4.5 million in 2021, then crashed by 120.9% to -$931000.0 in 2022, then crashed by 980.88% to -$10.1 million in 2023, then plummeted by 36.15% to -$13.7 million in 2024, then surged by 35.95% to -$8.8 million in 2025.
  • Its EBITDA was -$8.8 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$736000.0 in Q1 2025.